Novelogics Biotechnology
PrivateCompany Overview
Novelogics Biotechnology operates in Healthcare & Life Sciences and is based in Vancouver. It was founded in 2013.
Novelogics Biotechnology is a biotechnology company that develops monoclonal antibody immunotherapy drugs for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novelogics Biotechnology Comparables
Compare Novelogics Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AKSO Biopharmaceutical | 82% | |
| Aakha Biologics | 81% | |
| Biosion, Inc. | 78% |
For institutional investors. Book with your work email.
Novelogics Biotechnology Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Novelogics Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Novelogics Biotechnology's valuation, stock price, and market status.
Is Novelogics Biotechnology a public or private company?
Novelogics Biotechnology is a private company.
What is the current stock price of Novelogics Biotechnology?
Novelogics Biotechnology is a private company, so its shares have no public market price. Caplight tracks Novelogics Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Novelogics Biotechnology worth (valuation)?
Valuation information for Novelogics Biotechnology is not publicly available.
Can I buy Novelogics Biotechnology stock?
Novelogics Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Novelogics Biotechnology's last funding round?
Funding round information for Novelogics Biotechnology is not publicly available.
Who are the main investors in Novelogics Biotechnology?
Investor information for Novelogics Biotechnology is not publicly disclosed.
Will Novelogics Biotechnology IPO soon?
No public IPO plans have been announced for Novelogics Biotechnology.
How can I track Novelogics Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Novelogics Biotechnology's shares on secondary markets.